SN
Sunil Nandlal Singh
About Sunil Nandlal Singh
Data last updated:
Sunil Nandlal Singh is a Director at Onco-Life Cancer Centre Private Limited (since 2024), Director at Trident Lifecare Private Limited (since 2020) and Director at Aarti Vikas & Seva Mission (since 2024), and holds 3 more current directorships. The companies operate in Healthcare, Pharma and Service. The 3 current companies with reported revenue have a combined latest revenue of ₹66.92 Cr; the largest is Onco-Life Cancer Centre Private Limited at ₹53.18 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Onco-Life Cancer Centre Private Limited U93000MH2014PTC253216 | Director | 15 May 2024 | 2014 | ₹53.18 Cr (FY 2025) | Active |
 Trident Lifecare Private Limited U51397MH2020PTC338230 | Director | 25 Feb 2020 | 2020 | ₹13.71 Cr (FY 2025) | Active |
 Aarti Vikas & Seva Mission U74120MH2015NPL262875 | Director | 20 Jul 2024 | 2015 | ₹3.6 Lakh (FY 2025) | Active |
| Suvi Infra Private Limited U41001MH2026PTC468585 | Director | 17 Feb 2026 | 2026 | Active | |
| Advance International Institute Of Medical Science Private Limited U86100MH2025PTC452925 | Director | 24 Jul 2025 | 2025 | Active | |
| Advance Global Care Hospital Private Limited U86100MH2025PTC448101 | Director | 10 May 2025 | 2025 | Active |
Board colleagues of Sunil Nandlal Singh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Nandlal Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Nandlal Singh
Sunil Nandlal Singh currently holds 6 directorships: Onco-Life Cancer Centre Private Limited (Director, since 15 May 2024, revenue ₹53.18 Cr (FY 2025)); Trident Lifecare Private Limited (Director, since 25 Feb 2020, revenue ₹13.71 Cr (FY 2025)); Aarti Vikas & Seva Mission (Director, since 20 Jul 2024, revenue ₹3.6 Lakh (FY 2025)); Suvi Infra Private Limited (Director, since 17 Feb 2026); Advance International Institute Of Medical Science Private Limited (Director, since 24 Jul 2025); and 1 more.
Sunil Nandlal Singh was first appointed on 25 Feb 2020 as Director at Trident Lifecare Private Limited. The most recent appointment on record is 17 Feb 2026 at Suvi Infra Private Limited.
The 3 current companies of Sunil Nandlal Singh that report revenue have a combined latest revenue of ₹66.92 Cr: Onco-Life Cancer Centre Private Limited ₹53.18 Cr (FY 2025); Trident Lifecare Private Limited ₹13.71 Cr (FY 2025); Aarti Vikas & Seva Mission ₹3.6 Lakh (FY 2025).
The current boards of Sunil Nandlal Singh's companies include Abhay Harishchandra Shinde (Onco-Life Cancer Centre Private Limited), Anjali Uday Deshmukh (Onco-Life Cancer Centre Private Limited), Anurag Sanjay Motling (Onco-Life Cancer Centre Private Limited), Jaipalreddy Ramreddy Pogal (Onco-Life Cancer Centre Private Limited), Manoj Mahavir Lokhande (Onco-Life Cancer Centre Private Limited), Pratapsinh Laxmanrao Rajemahadik (Onco-Life Cancer Centre Private Limited), among others.